Individuals Coming Off Anti-Obesity Jabs Regain Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

New research indicates that people who come off new weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who stop traditional diet and exercise programs.

Findings released in a prominent medical journal shows that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such treatments must be informed of the potential of quick weight regain when the medication concludes," stated expert Dr. Susan Jebb.

This pace of recovery suggests a return to starting mass within about one and a half years.

Weighing Treatments

The analysis, which examined 37 of studies involving thousands of participants, compared the effects of these new drugs with other pills.

Researchers emphasize that people who shed pounds through lifestyle changes alone generally have a more gradual creep back—approximately 100 grams monthly—once they finish.

Understanding the Rapid Regain

Experts believe the mode of action of the injections explains the accelerated weight return.

The injections mimic a natural hormone called GLP-1, which helps regulate appetite.

"Artificially providing the hormone levels several times higher than normal could lead to the body to produce less of its endogenous GLP-1, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making binge eating much more probable."

A Lifelong Condition?

Health authorities suggest the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.

Professionals contend that, considering the likelihood of relapse, the treatment might need to be long-term.

This view is echoed by drug manufacturers, who say that the findings "emphasize the chronic character of excess weight," akin to managing diseases like diabetes.

User Accounts

People who have stopped the medication report a sudden return of cravings.

"I experienced something activating and I was suddenly extremely hungry," said an individual.

This challenge is exacerbated if individuals have not developed sustainable dietary or behavioural changes during therapy.

Widespread Adoption

Recent estimates indicate that a significant number of people in the UK have tried these injections in the last 12 months, with desire remaining high.

• Adoption is greater among women compared to men.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion obtain the medications through private prescriptions rather than public health services.

In conclusion, experts emphasize that while GLP-1 drugs are potent tools for weight loss, they are not a permanent cure and lasting health benefits likely depends on ongoing lifestyle changes.